Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming
この論文をさがす
説明
Cardiovascular disease is the leading cause of death globally. Cardiomyocytes (CMs) have poor regenerative capacity, and pharmacological therapies have limited efficacy in severe heart failure. Currently, there are several promising strategies for cardiac regeneration. The most promising approach to remuscularize failing hearts is cell transplantation therapy using newly generated CMs from exogenous sources, such as pluripotent stem cells. Alternatively, approaches to generate new CMs from endogenous cell sources
収録刊行物
-
- Regenerative Therapy
-
Regenerative Therapy 11 95-100, 2019-12
Elsevier
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1050285700309875968
-
- NII論文ID
- 120007132753
-
- ISSN
- 23523204
-
- HANDLE
- 2241/00161383
-
- PubMed
- 31304202
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- IRDB
- Crossref
- CiNii Articles
- KAKEN
- OpenAIRE